Literature DB >> 5693029

Intrascrotal sarcomas.

F Alexander.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5693029      PMCID: PMC2008398          DOI: 10.1038/bjc.1968.57

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  INTRASCROTAL EXTRATESTICULAR RHABDOMYOSARCOMA.

Authors:  L RAVICH; P H LERMAN; A SANDS
Journal:  J Urol       Date:  1964-08       Impact factor: 7.450

2.  PARATESTICULAR RHABDOMYOSARCOMA.

Authors:  V M AREAN; J A KREAGER
Journal:  Am J Clin Pathol       Date:  1965-05       Impact factor: 2.493

3.  Rhabdomyosarcoma of the epididymis.

Authors:  W F WALKER; H M CAMERON
Journal:  Br J Surg       Date:  1961-11       Impact factor: 6.939

4.  Rhabdomyosarcoma: a clinicopathological study and classification of 39 cases.

Authors:  R C HORN; H T ENTERLINE
Journal:  Cancer       Date:  1958 Jan-Feb       Impact factor: 6.860

5.  Rhabdomyosarcoma of the Skeletal Muscles.

Authors:  A P Stout
Journal:  Ann Surg       Date:  1946-03       Impact factor: 12.969

6.  [Tumors of the spermatic cord. (Apropos of a case of malignant leiomyoma)].

Authors:  E MEINARDI
Journal:  Minerva Chir       Date:  1961-09-30       Impact factor: 1.000

7.  Rhabdomyosarcoma of the spermatic cord. A review and case presentation.

Authors:  T A Fox; R L Collier
Journal:  Am Surg       Date:  1967-06       Impact factor: 0.688

8.  Leiomyosarcoma of the spermatic cord: a review of the literature and report of an additonal case.

Authors:  V N Kyle
Journal:  J Urol       Date:  1966-11       Impact factor: 7.450

9.  TESTICULAR NEOPLASMS IN INFANTS AND CHILDREN. II. TUMORS OF NON-GERM CELL ORIGIN.

Authors:  F HOLTZ; M R ABELL
Journal:  Cancer       Date:  1963-08       Impact factor: 6.860

  9 in total
  1 in total

Review 1.  Paratesticular liposarcoma: a report of two cases and review of the literature.

Authors:  J F Littles; R C Matter; G Herman
Journal:  J Natl Med Assoc       Date:  1992-11       Impact factor: 1.798

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.